# Cyto-Sen Therapeutics, Inc. — Form D

Cyto-Sen Therapeutics, Inc. of ORLANDO, FL, a company, filed a Form D exempt-offering notice with the SEC on 2016-12-13. The offering totals $856K, of which $800K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2016-12-13
- Form: D
- Accession: 0001691483-16-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $856K
- Amount sold: $800K
- Remaining: $56K
- Minimum investment: $50K
- Investors: 6
- Date of first sale: 2016-12-01
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-276137

## Issuer

- Name: Cyto-Sen Therapeutics, Inc.
- CIK: 0001691483
- Entity type: Corporation
- Jurisdiction: FLORIDA
- Incorporated: 2014
- Address: 3259 PROGRESS DRIVE, ORLANDO, FL, 32826
- Phone: 5104075383

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Stefan O Ciurea | Director | Houston, TX |
| Dean Anthony Lee | Director | Canal Winchester, OH |
| Philip R McKee | Director | Frisco, TX |

## More

- [CIK 1691483 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1691483&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001691483-16-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.